Dr. Skhumbuzo Ngozwana is CEO of Kiara Health and chairman of the board of Biovac, a South African vaccine manufacturer and a board member of the Federation of African Pharmaceutical Manufacturers Association. A tireless advocate for local biopharmaceutical manufacturing in Africa, he has worked with several global public health organizations. He has consulted for the World Health Organization, the United Nations Industrial Development Organization, and USP.
Bolstering capacity in Africa to manufacture COVID-19 vaccines will help facilitate access on the continent, prepare countries to graduate from donor-funded mechanisms, and prevent future vaccine access crises.
